Accurate detection of acetylcholine receptor antibodies is crucial for diagnosing myasthenia gravis (MG), a condition where the immune system disrupts nerve-muscle communication. However, there are concerns about the reliability of certain diagnostic assays.
While radioimmunoprecipitation assay (RIPA) is a key tool, it may not be the gold standard due to potential false positives. Clinicians should interpret antibody test results carefully alongside clinical symptoms to ensure proper patient management. This insight highlights the need for careful diagnosis and treatment planning, as noted in recent studies Zara et al. (2025).
Clinical Trials
This is a list of upcoming or ongoing clinical trials that are actively recruiting and have been listed or updated in the last two weeks:
More Info 
Add to Calendar